Improving reporting of infection events in clinical trials
Blood Adv
.
2024 Nov 26;8(22):5927-5928.
doi: 10.1182/bloodadvances.2024014102.
Authors
Heinz Ludwig
1
,
Nikhil C Munshi
2
,
Evangelos Terpos
3
,
Noopur Raje
4
,
Philippe Moreau
5
,
Ajay Nooka
6
Affiliations
1
Wilhelminen Cancer Research Institute, Department of Medicine I, Clinic Ottakring, Vienna, Austria.
2
Dana-Farber Cancer Institute and Boston VA Healthcare System, Boston, MA.
3
Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
4
Department of Hematology/Oncology, Center for Multiple Myeloma, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
5
Hematology Clinic, University Hospital Hotel-Dieu, Nantes, France.
6
Department of Hematology and Oncology, Winship Cancer Institute of Emory University, Atlanta, GA.
PMID:
39110989
PMCID:
PMC11662264
DOI:
10.1182/bloodadvances.2024014102
No abstract available